KAM

Kazazian Asset Management Portfolio holdings

AUM $82.9M
1-Year Est. Return 52.64%
This Quarter Est. Return
1 Year Est. Return
+52.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$72.4M
AUM Growth
-$49.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
62
New
Increased
Reduced
Closed

Top Buys

1
+$1.28M
2
+$722K
3
+$395K
4
CRWV
CoreWeave Inc
CRWV
+$277K
5
SRPT icon
Sarepta Therapeutics
SRPT
+$257K

Top Sells

1
+$13.7M
2
+$12.5M
3
+$10.1M
4
BABA icon
Alibaba
BABA
+$5.22M
5
CHWY icon
Chewy
CHWY
+$4.05M

Sector Composition

1 Communication Services 33.44%
2 Consumer Discretionary 29.2%
3 Financials 19.46%
4 Technology 8.32%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIDU icon
26
Baidu
BIDU
$44.2B
$551K 0.76%
6,420
-5,175
NESR
27
National Energy Services Reunited Corp
NESR
$1.32B
$504K 0.69%
83,650
+26,350
NBIS
28
Nebius Group N.V.
NBIS
$23.4B
$428K 0.59%
7,733
-9,733
SHOP icon
29
Shopify
SHOP
$204B
$421K 0.58%
3,650
HOV icon
30
Hovnanian Enterprises
HOV
$741M
$418K 0.58%
4,000
+400
BOXL icon
31
Boxlight
BOXL
$6.34M
$395K 0.54%
+224,500
ZS icon
32
Zscaler
ZS
$50.1B
$355K 0.49%
1,132
-283
MDB icon
33
MongoDB
MDB
$30B
$343K 0.47%
1,635
-843
PYPL icon
34
PayPal
PYPL
$62.7B
$333K 0.46%
4,474
-7,550
CGNX icon
35
Cognex
CGNX
$6.44B
$283K 0.39%
8,920
-13,644
CRWV
36
CoreWeave Inc
CRWV
$42.7B
$277K 0.38%
+1,700
KWEB icon
37
KraneShares CSI China Internet ETF
KWEB
$9.01B
$272K 0.37%
7,933
-8,790
SRPT icon
38
Sarepta Therapeutics
SRPT
$1.87B
$257K 0.35%
+15,000
CORZ icon
39
Core Scientific
CORZ
$5.01B
$256K 0.35%
15,000
-21,000
NET icon
40
Cloudflare
NET
$78.6B
$245K 0.34%
1,250
-1,250
TTD icon
41
Trade Desk
TTD
$21.2B
$221K 0.3%
3,070
-3,292
INDV icon
42
Indivior
INDV
$3.8B
$202K 0.28%
13,583
-65,842
DHX icon
43
DHI Group
DHX
$82.6M
$151K 0.21%
50,873
-5,327
SLQT icon
44
SelectQuote
SLQT
$289M
$134K 0.18%
56,330
-72,370
CRON
45
Cronos Group
CRON
$973M
$120K 0.16%
62,605
-5,245
REGN icon
46
Regeneron Pharmaceuticals
REGN
$72.1B
– –
-560
PFE icon
47
Pfizer
PFE
$147B
– –
-18,050
OKTA icon
48
Okta
OKTA
$14.9B
– –
-3,000
NVS icon
49
Novartis
NVS
$252B
– –
-1,819
MRUS icon
50
Merus
MRUS
$7.28B
– –
-6,368
1
2
3